Attorney General Marty Jackley says South Dakota is using its share of a large multistate settlement with a drug company to fund behavioral health initiatives.
Jackley and attorneys general in 35 other states in April 2012 reached a $200 million settlement with Janssen Pharmaceuticals Inc. over allegations it marketed anti-psychotic drugs for non-approved uses.
Janssen did not admit wrongdoing, but it agreed not to promote the drugs for off-label use or make misleading claims.
South Dakota's share of the settlement was just under $2.6 million. Jackley on Monday said the money is funding treatment, education, training and outreach programs.
The state Consumer Protection Division and Department of Social Services determined the funding uses.